These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 9354203)
1. Twice a day quadruple therapy (bismuth subsalicylate, tetracycline, metronidazole plus lansoprazole) for treatment of Helicobacter pylori infection. Graham DY; Hoffman J; el-Zimaity HM; Graham DP; Osato M Aliment Pharmacol Ther; 1997 Oct; 11(5):935-8. PubMed ID: 9354203 [TBL] [Abstract][Full Text] [Related]
2. 4-day lansoprazole quadruple therapy: a highly effective cure for Helicobacter pylori infection. de Boer WA; van Etten RJ; Schade RW; Ouwehand ME; Schneeberger PM; Tytgat GN Am J Gastroenterol; 1996 Sep; 91(9):1778-82. PubMed ID: 8792697 [TBL] [Abstract][Full Text] [Related]
3. Bismuth-based quadruple therapy for Helicobacter pylori - a single triple capsule plus lansoprazole. De Boer WA; Van Etten RJ; Van De Wouw BA; Schneeberger PM; Van Oijen AH; Jansen JB Aliment Pharmacol Ther; 2000 Jan; 14(1):85-9. PubMed ID: 10632650 [TBL] [Abstract][Full Text] [Related]
4. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial. Chey WD; Fisher L; Elta GH; Barnett JL; Nostrant T; DelValle J; Hasler WL; Scheiman JM Am J Gastroenterol; 1997 Sep; 92(9):1483-6. PubMed ID: 9317068 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness of quadruple therapy using lansoprazole, instead of omeprazole, in curing Helicobacter pylori infection. de Boer WA; van Etten RJ; Lai JY; Schneeberger PM; van de Wouw BA; Driessen WM Helicobacter; 1996 Sep; 1(3):145-50. PubMed ID: 9398895 [TBL] [Abstract][Full Text] [Related]
6. Treatment of Helicobacter pylori infection in clinical practice in the United States: results from 224 patients. Kearney DJ; Brousal A Dig Dis Sci; 2000 Feb; 45(2):265-71. PubMed ID: 10711436 [TBL] [Abstract][Full Text] [Related]
8. A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy. Magaret N; Burm M; Faigel D; Kelly C; Peterson W; Fennerty MB Dig Dis; 2001; 19(2):174-8. PubMed ID: 11549829 [TBL] [Abstract][Full Text] [Related]
9. Eradication of Helicobacter pylori infection with proton pump-based triple therapy in patients in whom bismuth-based triple therapy failed. Mera R; Realpe JL; Bravo LE; DeLany JP; Correa P J Clin Gastroenterol; 1999 Jul; 29(1):51-5. PubMed ID: 10405232 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of quadruple therapy with pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment for Helicobacter pylori infection. Boixeda D; Bermejo F; Martín-De-Argila C; López-Sanromán A; Defarges V; Hernández-Ranz F; Milicua JM; García-Plaza A Aliment Pharmacol Ther; 2002 Aug; 16(8):1457-60. PubMed ID: 12182745 [TBL] [Abstract][Full Text] [Related]
11. One-day intensified lansoprazole-quadruple therapy for cure of Helicobacter pylori infection. de Boer WA; van Etten RJ; Schade RW; Ouwehand ME; Schneeberger PM; van Unnik AJ; Tytgat GN Aliment Pharmacol Ther; 1997 Feb; 11(1):109-12. PubMed ID: 9042982 [TBL] [Abstract][Full Text] [Related]
12. Twice daily (mid-day and evening) quadruple therapy for H. pylori infection in the United States. Graham DY; Belson G; Abudayyeh S; Osato MS; Dore MP; El-Zimaity HM Dig Liver Dis; 2004 Jun; 36(6):384-7. PubMed ID: 15248377 [TBL] [Abstract][Full Text] [Related]
13. A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance. Tsay FW; Wu DC; Yu HC; Kao SS; Lin KH; Cheng JS; Wang HM; Chen WC; Sun WC; Tsai KW; Hsu PI Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807915 [TBL] [Abstract][Full Text] [Related]
15. Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. Liou JM; Fang YJ; Chen CC; Bair MJ; Chang CY; Lee YC; Chen MJ; Chen CC; Tseng CH; Hsu YC; Lee JY; Yang TH; Luo JC; Chang CC; Chen CY; Chen PY; Shun CT; Hsu WF; Hu WH; Chen YN; Sheu BS; Lin JT; Wu JY; El-Omar EM; Wu MS; Lancet; 2016 Nov; 388(10058):2355-2365. PubMed ID: 27769562 [TBL] [Abstract][Full Text] [Related]
16. Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection. Dore MP; Graham DY; Mele R; Marras L; Nieddu S; Manca A; Realdi G Am J Gastroenterol; 2002 Apr; 97(4):857-60. PubMed ID: 12003419 [TBL] [Abstract][Full Text] [Related]
17. Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection. Wong WM; Gu Q; Chu KM; Yee YK; Fung FM; Tong TS; Chan AO; Lai KC; Chan CK; Wong BC Aliment Pharmacol Ther; 2006 Feb; 23(3):421-7. PubMed ID: 16423001 [TBL] [Abstract][Full Text] [Related]
18. Four-day quadruple therapy as a routine treatment for Helicobacter pylori infection. de Boer SY; Siem TH Aliment Pharmacol Ther; 1997 Dec; 11(6):1119-21. PubMed ID: 9663839 [TBL] [Abstract][Full Text] [Related]
19. Rescue Therapy for Helicobacter pylori Eradication: A Randomized Non-Inferiority Trial of Amoxicillin or Tetracycline in Bismuth Quadruple Therapy. Chen Q; Zhang W; Fu Q; Liang X; Liu W; Xiao S; Lu H Am J Gastroenterol; 2016 Dec; 111(12):1736-1742. PubMed ID: 27670603 [TBL] [Abstract][Full Text] [Related]
20. Triple or quadruple tetracycline-based therapies versus standard triple treatment for Helicobacter pylori treatment. Songür Y; Senol A; Balkarli A; Baştürk A; Cerçi S Am J Med Sci; 2009 Jul; 338(1):50-3. PubMed ID: 19474657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]